Sakra World Hospital, a joint venture between SECOM and Toyota Tsusho Corporation (TTC), has announced plans to establish a healthcare facility in Banaswadi, Bengaluru, with an expected investment of Rs 1,000 crore.
Union Minister Dr Jitendra Singh recently addressed the “Doctors’ Sammelan†organized by BJP, where he shared his perspective on the challenges faced by the healthcare sector in Jammu & Kashmir.
For the past eighteen months, Gujarat's pharmaceutical companies have been grappling with concerns over price erosion in the US market. However, recent developments indicate a welcome resurgence in their US market revenues.
The Brihanmumbai Municipal Corporation (BMC) has set up a ten-member committee to monitor the healthcare facilities and challenges faced by the transgender population in civic-run hospitals.
Recent data released by the Indian Election Commission on March 14 reveals that around 35 pharmaceutical companies in India have contributed approximately Rs 1,000 crore to political parties through electoral bonds.
The Drugs Technical Advisory Board (DTAB) recently held a meeting in January. The discussion revolved around prohibiting veterinary use of nonsteroidal anti-inflammatory drug (NSAID) Nimesulide formulations for vulture conservation.
Understanding the pressing need to engage all healthcare providers to protect kids' well-being amid the difficulties of ecological contamination and environmental change.
Sibylla Biotech declared a drug discovery joint pact with Osaka-settled Ono pharma for getting to Sibylla's state of the art Pharmacological Protein Inactivation by Folding Intermediates Targeting (PPI-FIT) innovation to distinguish and foster...
Bayer and Aignostics GmbH declared an strategic partnership on artificial intelligence (AI)- fueled approaches with applications in precision oncology drug innovative work. Aignostics is a side project from one of the world's driving medical...
Eris Lifesciences declared the acquisition of Biocon Biologics' India-marked detailing business for Rs. 1,242 crore. Eris has likewise marked a 10-year supply concurrence with Biocon Biologics on account of this agreement...